Direct vs Standard SLT for Glaucoma: A Noninferiority Trial

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Both procedures aim to lower eye pressure and prevent vision loss. DSLT is a newer, non-contact technique that may improve comfort and efficiency. Participants will be randomly assigned to receive either DSLT or SLT and followed for 12 months to assess eye pressure, safety, and treatment outcomes.
Epistemonikos ID: 7257c696100ff2cc76575ff8e83603a6b0220e78
First added on: Feb 14, 2026